GlassScriptPhysician profile
Lester K Leung
NPI 1851394126
$10,154.38
in general payments reported to CMS, 2019-2025
39 companies · $2,986 in 2025
The $2,986 reported for 2025 was more than what 88% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,115 · 2020: $839 · 2021: $336 · 2022: $557 · 2023: $1,539 · 2024: $1,781 · 2025: $2,986.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,306.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $1,241.74 | 2019-2025 | Camzyos, Eliquis |
| Aop Health US, LLC | $1,234.50 | 2025 | Rapiblyk |
| Pfizer INC. | $853.80 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $840.29 | 2019-2025 | Lifevest |
| Amgen INC. | $681.31 | 2019-2025 | Repatha |
| Janssen Pharmaceuticals, INC | $587.97 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $561.19 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $556.03 | 2019-2025 | Farxiga, Wainua |
| Novartis Pharmaceuticals Corporation | $538.90 | 2019-2025 | |
| Scpharmaceuticals INC. | $442.44 | 2023-2025 | |
| Boston Scientific Corporation | $252.43 | 2019-2025 | Watchman, Watchman Flx |
| Medtronic, INC. | $215.27 | 2021-2024 | Micra, Linq II, Aurora Ev-Icd Mri Surescan |
| Gilead Sciences, INC. | $207.50 | 2019 | |
| Sanofi-Aventis U.S. LLC | $186.83 | 2019-2024 | |
| Amarin Pharma, INC. | $161.50 | 2019-2022 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $149.10 | 2019-2025 | Evkeeza |
| Novo Nordisk INC | $139.26 | 2024-2025 | Wegovy, Ozempic |
| Esperion Therapeutics, INC. | $133.38 | 2023-2025 | Nexletol |
| Silk Road Medical, INC. | $125.00 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Abbott Laboratories | $123.93 | 2022-2023 | Amplatzer Amulet, Thoratec Heartmate 3 Lvas Implant Kit, Aveir |
| Alnylam Pharmaceuticals INC. | $121.68 | 2025 | |
| Preventice Services, LLC | $98.79 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $98.30 | 2023-2024 | Inpefa |
| Kestra Medical Technology Services, INC. | $94.52 | 2025 | Assure Wcd |
| Merck Sharp & Dohme LLC | $57.70 | 2022-2023 | Verquvo |
| Lundbeck LLC | $55.38 | 2019 | |
| Lantheus Medical Imaging, INC. | $52.46 | 2023 | Definity |
| Medtronic Vascular, INC. | $51.47 | 2019-2020 | |
| Atricure, INC. | $44.59 | 2019-2021 | |
| Kiniksa Pharmaceuticals, LTD. | $38.48 | 2023 | Arcalyst |
| Irhythm Technologies, INC. | $36.63 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Bayer Healthcare Pharmaceuticals INC. | $34.85 | 2024-2025 | |
| Actelion Pharmaceuticals US, INC. | $25.82 | 2025 | Opsynvi |
| Cvrx, INC. | $24.55 | 2024 | Barostim Neo System |
| Philips North America LLC | $21.63 | 2024 | (5091) Amb Mon & Diag Und |
| Heartflow, INC. | $18.29 | 2025 | |
| Emd Serono, INC. | $17.17 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $16.63 | 2019 | |
| Biotronik INC. | $13.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lester Leung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.